FILANA THERAPEUTICS, INC.
FLNA · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Barry Richard: Form 4
Insider disclosure · Filed · Report period 29 Sep 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Latest financial period: Q1 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- FLNA · 14817C107 - Common Stock
Company details and SEC sources
CIK 0001069530 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- FLNA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 6801 N Capital Of Texas Highway, Building 1; Suite 300, Austin, TX, 78731
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- CASSAVA SCIENCES INC (to 19 Feb 2026), PAIN THERAPEUTICS INC (to 25 Mar 2019)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields